-
Tuberculosis has been reduced to record lows in the United States since the major hospital outbreaks in the 1980s and '90s, but there is growing concern that deadly strains of extensively drug-resistant (XDR) TB may arise at a point of U.S. disinterest and waning funding, the very trough of the so-called "U-shaped curve of concern" that historically precedes TB resurgence.
-
-
When a day care worker reported to employee health at Dartmouth-Hitchcock Medical Center in Lebanon, NH, with a severe, spasmatic cough that had lasted more than two weeks, an employee health nurse immediately thought of pertussis.
-
If extensively drug-resistant tuberculosis (XDR-TB) emerges to become an infection control threat in the nation's hospitals, the lessons learned from past outbreaks will prove invaluable.
-
A review of evaluable multidrug-resistant tuberculosis (MDR-TB) cases that occurred in the United States from 1993 to 2006 found that 49 (3%) met the definition for extensively drug-resistant XDR-TB cases. Of those, 17 (35%) were reported during 2000-2006, the Centers for Disease Control and Prevention reports.
-
Even though multidrug-resistant (MDR) and extensively drug resistant (XDR) TB are at extremely low levels in the United States, the cost of a single infection is staggering, Julie Gerberding, MD, MPH, director for the Centers for Disease Control and Prevention recently told Congress.
-
Compared with a lower dose, intensive treatment with atorvastatin in patients with stable coronary disease significantly reduces hospitalizations for HF.
-
Current AP schedules do not appear to prevent catheter-related thrombosis. Systemic VTE and mortality, however, appeared lower after prophylaxis.
-
Elimination of daily routine CXRs reduced the number of CXRs in a mixed medical-surgical ICU, while not affecting readmission rate and ICU and hospital mortality rates.
-